Alkaline-extracted influenza subunit vaccine

Area of Science:

• Virology
• Vaccine Development
• Biochemistry

Background:

• Influenza virus is a significant global health concern.
• Current influenza vaccines often use inactivated whole virus.
• Developing safer and more effective subunit vaccines is an ongoing research priority.

Purpose of the Study:

• To investigate the efficacy of alkaline solvents for extracting influenza virus structural proteins.
• To characterize the extracted hemagglutinin and neuraminidase antigens.
• To evaluate the immunogenicity of these alkaline-extracted antigens as potential subunit vaccines.

Main Methods:

• Influenza virus concentrates were treated with alkaline solvents.
• Polyacrylamide gel electrophoresis was used to analyze solubilized proteins.
• Two forms of hemagglutinin antigen (39S and 23S) were recovered.
• Dose-response assays in mice were conducted to assess antibody induction.

Main Results:

• Alkaline solvent treatment released a major fraction of viral structural proteins, primarily hemagglutinin and neuraminidase.
• Both hemagglutination-inhibiting and neuraminidase antibodies were induced in mice.
• Antibody responses were comparable to those achieved with inactivated whole virus immunization.
• High yields of pure, immunogenic protective antigens were obtained.

Conclusions:

• Alkaline-extracted influenza protein preparations are rich in protective antigens.
• These preparations demonstrate significant immunogenic potency.
• The purity and yield of antigens, along with the absence of harmful reagents, support their consideration as subunit vaccines for human use.